Abstract

GAO, Tianshu; WANG, Zhenting  and  LIU, Yi. Matrix metalloproteinase 2 expression and disease-free survival of patients with osteosarcoma: a meta-analysis. Invest. clín [online]. 2023, vol.64, n.2, pp.255-262.  Epub Sep 08, 2023. ISSN 0535-5133.  https://doi.org/10.54817/ic.v64n2a10.

Numerous studies indicate the influence of matrix metalloproteinase-2 (MMP-2) overexpression in osteosarcoma (OS) outcomes. A previous study has systematically analyzed the correlation between MMP-2 expression and the prognosis of OS. However, the results of subsequent studies remain inconsistent. Therefore, a meta-analysis in terms of the prognostic value of MMP- 2 expression in OS was conducted. We employed the Newcastle-Ottawa scale (NOS) to evaluate the quality of the studies. Five studies involving 284 patients were included. The relative risk (RR) with a corresponding 95% confidence interval (95%CI) was calculated to appraise the predictive value of MMP-2 positive expression for OS recurrence and metastasis, and lower disease-free survival. It was indicated by the results that MMP-2 positive individuals with OS had higher recurrence and metastasis rates than negative individuals (RR=1.85, 95%CI:1.16-2.93, p<0.01). Sensitivity analysis showed that the combined RR was stable. There was no significant change, independently of whichever article was excluded.

Keywords : meta-analysis; MMP-2; osteosarcoma; prognosis.

        · abstract in Spanish     · text in English     · English ( pdf )